Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celularity IncCELU · Entity 7145 | See Remarks | April 13, 2022 | April 29, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celularity Inc
Report date April 13, 2022 · Filed April 29, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 16,405 |
Reported balance
After 2022-04-13 transaction · row 1
1 source rowRow 1 · 2022-04-13 · Grant · Acquired 16,405 · Balance 16,405 F1: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.16 · Expires 2032-04-13 | Direct | 48,100 |
Reported balance
After 2022-04-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-04-13 · Grant · Acquired 48,100 · Balance 48,100 F2: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
F2: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2022 Filed Apr 29, 2022 01:04 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 48,100 | $0.00 Strike: $10.16 | $0.00 |
DisclosureSEC source: 0000899243-22-015910 · doc4.xml · derivative · entry 2 Dunn Keary · CIK 0001868779 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,100 Underlying: Class A Common Stock · 48,100 shares Expires 2032-04-13 F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
| April 13, 2022 Filed Apr 29, 2022 01:04 UTC | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 16,405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-015910 · doc4.xml · nonDerivative · entry 1 Dunn Keary · CIK 0001868779 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,405 F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 22:08 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 76,859 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0001213900-21-047748 · ownership.xml · derivative · entry 1 Dunn Keary · CIK 0001868779 · General Counsel & EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,859 Underlying: Class A Common Stock · 76,859 shares Expires 2031-09-09 F1 · derivative.exercise_date: This option shall vest and become exercisable as follows: 50% is fully-vested as of the grant date; 50% is subject to time-based vesting over a four-year period from the July 16, 2021 closing of the business combination, with 25% of this tranche vesting on the one-year anniversary of the closing (July 16, 2022), and the remainder vesting monthly thereafter so that vested in full on the four-year anniversary of the business combination closing date, and subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
| July 16, 2021 Filed Jul 16, 2021 21:40 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 279,089 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-21-046979 · doc4.xml · derivative · entry 2 Dunn Keary · CIK 0001868779 · General Counsel & Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,089 Underlying: Class A Common Stock · 279,089 shares Expires 2031-07-16 F1 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 23, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. Read SEC document |
| July 16, 2021 Filed Jul 16, 2021 21:40 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 105,207 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-21-046979 · doc4.xml · derivative · entry 1 Dunn Keary · CIK 0001868779 · General Counsel & Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,207 Underlying: Class A Common Stock · 105,207 shares Expires 2031-07-16 F1 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 23, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 01:08 UTC Amendment | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 384,297 | $0.00 Strike: $3.70 | $0.00 |
DisclosureSEC source: 0001209191-21-047508 · doc4a.xml · derivative · entry 1 Dunn Keary · CIK 0001868779 · General Counsel & Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,297 Underlying: Class A Common Stock · 384,297 shares Expires 2031-07-16 F2 · price: Pursuant to the Merger Agreement and Plan of Merger and Reorganization, dated January 8, 2021 (the "Business Combination Agreement"), by and among GX Acquisition Corp. ("GX"), Alpha First Merger Sub Corp., Celularity LLC and Celularity Inc. ("Legacy Celularity"), each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio. Upon consummation of the business combination, GX changed its name to "Celularity Inc." F1 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 23, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.